Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids

被引:22
|
作者
Mallory, S
Sommer, M
Arvin, AM [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Immunol Microbiol, Stanford, CA 94305 USA
来源
关键词
D O I
10.1086/514277
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The contributions of the glycoproteins gI (ORF67) and gE (ORF68) to varicella-zoster virus (VZV) replication were investigated in deletion mutants made by using cosmids with VZV DNA derived from the Oka strain. These experiments demonstrated that gI was not required for VZV replication in vitro but gE appeared to be. Although VZV gI was not required, its deletion or mutation resulted in a significant decrease in infectious virus yields, and it disrupted syncytial formation and altered the conformation and distribution of gE in infected cells. Normal cell-to-cell spread and replication kinetics were restored when gI was expressed from a non-native locus in the VZV genome. The expression of intact gI, the ORF67 gene product, is required for efficient VZV replication.
引用
收藏
页码:S22 / S26
页数:5
相关论文
共 50 条
  • [21] VARICELLA-ZOSTER VIRUS (VZV) INFECTION FOLLOWING RENAL-TRANSPLANTATION
    STEVENS, ME
    HILLIS, AN
    HART, A
    BONE, JM
    [J]. KIDNEY INTERNATIONAL, 1984, 26 (04) : 655 - 655
  • [22] SEROLOGICAL REACTIVITY OF MONOCLONAL-ANTIBODIES TO VARICELLA-ZOSTER (VZV) VIRUS
    FORGHANI, B
    SCHMIDT, NJ
    [J]. IMMUNOLOGICAL COMMUNICATIONS, 1983, 12 (01): : 61 - 61
  • [23] Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH
    Duus, KM
    Grose, C
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (12) : 8961 - 8971
  • [24] Neutralizing human antibodies to varicella-zoster virus (VZV) derived from a VZV patient recombinant antibody library
    Kausmally, L
    Waalen, K
    Lobersli, I
    Hvattum, E
    Berntsen, G
    Michaelsen, TE
    Brekke, OH
    [J]. JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 3493 - 3500
  • [25] Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction
    Takahashi, M
    Kamiya, H
    Asano, Y
    Shiraki, K
    Baba, K
    Otsuka, T
    Hirota, T
    Yamanishi, K
    [J]. IMMUNITY TO AND PREVENTION OF HERPES ZOSTER, 2001, 17 : 161 - 172
  • [27] CROSS-REACTIVITY BETWEEN HERPES-SIMPLEX VIRUS (HSV) AND VARICELLA-ZOSTER VIRUS (VZV) ENVELOPE GLYCOPROTEINS
    EDSON, CM
    HOSLER, BA
    WATERS, DJ
    THORLEYLAWSON, DA
    [J]. FEDERATION PROCEEDINGS, 1985, 44 (03) : 693 - 693
  • [28] VARICELLA-ZOSTER VIRUS (VZV) INFECTION IN HIV-1 INFECTED CHILDREN
    SRUGO, I
    COURVILLE, T
    ISRAELE, V
    WITTEK, A
    BRUNELL, P
    [J]. PEDIATRIC RESEARCH, 1991, 29 (04) : A185 - A185
  • [29] The anti-viral effects of interferon-α on varicella-zoster virus (VZV).
    Ku, Chia-Chi
    Schaap, Anne
    Arvin, Ann
    [J]. CLINICAL IMMUNOLOGY, 2006, 119 : S181 - S181
  • [30] Transcriptional pattern of Varicella-zoster virus glycoproteins E and I
    Rahaus, M
    Wolff, MH
    [J]. INTERVIROLOGY, 2000, 43 (03) : 180 - 184